Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer ; volume:10 ; number:1 ; day:6 ; month:3 ; year:2020 ; pages:1-13 ; date:12.2020
EJNMMI Research ; 10, Heft 1 (6.3.2020), 1-13, 12.2020
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-020-0598-2
- URN
-
urn:nbn:de:101:1-2020052619352551988873
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jilg, Cordula
- Reichel, Kathrin
- Stoykow Grillo, Christian
- Rischke, H. Christian
- Bartholomä, Mark
- Drendel, Vanessa
- Büren, Moritz von
- Schultze-Seemann, Wolfgang
- Meyer, Philipp Tobias
- Mix, Michael
- SpringerLink (Online service)
Other Objects (12)
![Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?](/assets/placeholder/searchResultMediaUnknown.png)
Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?
Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle
99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle
Ansätze zur Optimierung der Datenverarbeitung in der Positronen-Emissions-Tomographie
Ansätze zur Optimierung der Datenverarbeitung in der Positronen-Emissions-Tomographie
[177Lu]Lu-PSMA-617 salivary gland uptake characterized by quantitative in vitro autoradiography
Präoperatives funktionelles brain mapping bei Hirntumorpatienten mittels der 18Fluordeoxyglukose-Positronen-Emmissions-Tomographie
Early PSA change after [177Lu]PSMA-617 radioligand therapy as a predicator of biochemical response and overall survival
68Ga-HBED-CC-PSMA PET/CT versus histopathology In primary localized prostate cancer: a voxel-wise comparison
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [177Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside
Neurodegenerative Erkrankungen
Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?
Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle
99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle
Ansätze zur Optimierung der Datenverarbeitung in der Positronen-Emissions-Tomographie
Ansätze zur Optimierung der Datenverarbeitung in der Positronen-Emissions-Tomographie
[177Lu]Lu-PSMA-617 salivary gland uptake characterized by quantitative in vitro autoradiography
Präoperatives funktionelles brain mapping bei Hirntumorpatienten mittels der 18Fluordeoxyglukose-Positronen-Emmissions-Tomographie
Early PSA change after [177Lu]PSMA-617 radioligand therapy as a predicator of biochemical response and overall survival
68Ga-HBED-CC-PSMA PET/CT versus histopathology In primary localized prostate cancer: a voxel-wise comparison
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [177Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside
Neurodegenerative Erkrankungen
Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?
Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle
99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle
Ansätze zur Optimierung der Datenverarbeitung in der Positronen-Emissions-Tomographie
Ansätze zur Optimierung der Datenverarbeitung in der Positronen-Emissions-Tomographie
[177Lu]Lu-PSMA-617 salivary gland uptake characterized by quantitative in vitro autoradiography
Präoperatives funktionelles brain mapping bei Hirntumorpatienten mittels der 18Fluordeoxyglukose-Positronen-Emmissions-Tomographie
Early PSA change after [177Lu]PSMA-617 radioligand therapy as a predicator of biochemical response and overall survival
68Ga-HBED-CC-PSMA PET/CT versus histopathology In primary localized prostate cancer: a voxel-wise comparison
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [177Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside